Clearside Biomedical
Stock Forecast, Prediction & Price Target
Clearside Biomedical Financial Estimates
Clearside Biomedical Revenue Estimates
Clearside Biomedical EBITDA Estimates
Clearside Biomedical Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $29.57M N/A | $1.32M -95.51% | $8.22M 519.89% | Avg: $5.19M Low: $522.39K High: $14.05M avg. -36.81% | Avg: $24.77M Low: $4.80M High: $60.51M avg. 376.55% | Avg: $69.57M Low: $13.49M High: $169.96M avg. 180.86% | Avg: $146.22M Low: $28.36M High: $357.22M avg. 110.17% |
Net Income
% change YoY
| $376K N/A | $-34.07M -9161.52% | $-32.48M 4.65% | Avg: $-44.74M Low: $-43.88M High: $-27.19M avg. -37.73% | Avg: $-43.43M Low: $-48.20M High: $-12.97M avg. 2.92% | Avg: $-31.93M Low: $-91.83M High: $1.52M avg. 26.47% | Avg: $32.96M Low: $-1.57M High: $94.79M avg. 203.22% |
EBITDA
% change YoY
| $-449K N/A | $-29.60M -6494.20% | $-23.05M 22.12% | Avg: $-4.17M Low: $-11.28M High: $-419.50K avg. 81.89% | Avg: $-19.89M Low: $-48.59M High: $-3.85M avg. -376.55% | Avg: $-55.86M Low: $-136.48M High: $-10.83M avg. -180.86% | Avg: $-117.42M Low: $-286.86M High: $-22.77M avg. -110.17% |
EPS
% change YoY
| $0.01 N/A | -$0.57 -9006.24% | -$0.53 7.01% | Avg: -$0.6 Low: -$0.71 High: -$0.44 avg. -12.57% | Avg: -$0.58 Low: -$0.78 High: -$0.21 avg. 2.37% | Avg: -$0.52 Low: -$1.49 High: $0.02 avg. 11.30% | Avg: $0.53 Low: -$0.03 High: $1.53 avg. 203.22% |
Operating Expenses
% change YoY
| $30.20M N/A | $31.4M 3.96% | $32.71M 4.18% | Avg: $20.59M Low: $2.06M High: $55.67M avg. -37.05% | Avg: $98.13M Low: $19.03M High: $239.75M avg. 376.55% | Avg: $275.64M Low: $53.46M High: $673.39M avg. 180.86% | Avg: $579.32M Low: $112.37M High: $1.41B avg. 110.17% |
FAQ
What is Clearside Biomedical stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 48.72% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -43.88M, average is -44.74M and high is -27.19M.
What is Clearside Biomedical stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 157.69% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $522.39K, average is $5.19M and high is $14.05M.
What is Clearside Biomedical stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 51.08% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.71, average is -$0.6 and high is $-0.44.